BIOMARIN PHARMACEUTICAL INC Goodwill, Acquired During Period
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Goodwill, Acquired During Period of $148.13 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2016-02-29
- BIOMARIN PHARMACEUTICAL INC goodwill, acquired during period for the quarter ending 2015-12-31 was $0.00.
- BIOMARIN PHARMACEUTICAL INC goodwill, acquired during period for the quarter ending 2015-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC goodwill, acquired during period for the quarter ending 2015-06-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC goodwill, acquired during period for the quarter ending 2015-03-31 was $148.13M.
- BIOMARIN PHARMACEUTICAL INC goodwill, acquired during period for fiscal 2015 was $148.13M.
- BIOMARIN PHARMACEUTICAL INC goodwill, acquired during period for fiscal 2013 was $2.71M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $148.13M 10-K · filed 2016-02-29 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $0.00 derived: sum of 2 quarters · filed 2015-11-02 | $148.13M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $148.13M 10-Q · filed 2015-08-05 | ||
| 2015-03-31 | $148.13M 10-Q · filed 2015-05-05 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | -$717.00K derived: sum of 2 quarters · filed 2014-02-26 | -$717.00K derived: sum of 3 quarters · filed 2014-02-26 | $2.71M 10-K · filed 2014-02-26 |
| 2013-09-30 | -$717.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | -$717.00K derived: sum of 2 quarters · filed 2013-10-28 | $2.71M 10-Q · filed 2013-10-28 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $3.43M 10-Q · filed 2013-07-29 | ||
| 2013-03-31 | $3.43M 10-Q · filed 2013-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |